{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:09:31Z","timestamp":1769018971027,"version":"3.49.0"},"reference-count":54,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T00:00:00Z","timestamp":1486425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"&quot;Victor Babes&quot; University of Medicine and Pharmacy, Timisoara, Romania","award":["PII-C4-TC-2016-16441-09"],"award-info":[{"award-number":["PII-C4-TC-2016-16441-09"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Thrombospondin-1 (TSP-1) is a potent endogenous inhibitor of both physiological and pathological angiogenesis, widely studied as a target in drug development for treating cancer. Several studies performed in the cardiovascular field on TSP-1 are contradictory, the role of TSP-1 in the physiopathology of cardiovascular disorders (CVDs) being, for the moment, incompletely understood and may be due to the presence of several domains in its structure which can stimulate many cellular receptors. It has been reported to inhibit NO-mediated signaling and to act on the angiogenesis, tissue perfusion, endothelial cell proliferation, and homeostasis, so we aimed to quantify the effect Perindopril has on TSP-1 plasma levels in hypertensive patients with endothelial dysfunction in comparison with other antihypertensive drugs, such as beta blockers, calcium channel blockers, and diuretics, in a chronic treatment. As a conclusion, patients under treatment with Perindopril had increased plasma levels of TSP-1 compared with other hypertensive patients and with the control group. The results of this study confirms the pleiotropic properties of Perindopril: anti-proliferative, anti-inflammatory, with effects showed by quantifying a single biomarker: TSP-1.<\/jats:p>","DOI":"10.3390\/ijms18020348","type":"journal-article","created":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T12:08:18Z","timestamp":1486469298000},"page":"348","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Perindopril Induces TSP-1 Expression in Hypertensive Patients with Endothelial Dysfunction in Chronic Treatment"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3194-2012","authenticated-orcid":false,"given":"Valentina","family":"Buda","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy, Victor Babe\u015f University of Medicine and Pharmacy, 2 EftimieMurgu, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minodora","family":"Andor","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Victor Babe\u015f University of Medicine and Pharmacy, 2 EftimieMurgu, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucian","family":"Petrescu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Victor Babe\u015f University of Medicine and Pharmacy, 2 EftimieMurgu, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Cristescu","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Victor Babe\u015f University of Medicine and Pharmacy, 2 EftimieMurgu, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Baibata","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Victor Babe\u015f University of Medicine and Pharmacy, 2 EftimieMurgu, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirela","family":"Voicu","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Victor Babe\u015f University of Medicine and Pharmacy, 2 EftimieMurgu, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melania","family":"Munteanu","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, VasileGoldis Western University, 86 LiviuRebreanu, 310045 Arad, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioana","family":"Citu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Victor Babe\u015f University of Medicine and Pharmacy, 2 EftimieMurgu, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0497-0405","authenticated-orcid":false,"given":"Calin","family":"Muntean","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Victor Babe\u015f University of Medicine and Pharmacy, 2 EftimieMurgu, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Octavian","family":"Cretu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Victor Babe\u015f University of Medicine and Pharmacy, 2 EftimieMurgu, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2117-0474","authenticated-orcid":false,"given":"Mirela","family":"Tomescu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Victor Babe\u015f University of Medicine and Pharmacy, 2 EftimieMurgu, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2017,2,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nrc2561","article-title":"Regulation of nitric oxide signalling by thrombospondin 1: Implications for anti-angiogenic therapies","volume":"9","author":"Isenberg","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jss.2004.05.015","article-title":"The role of thrombospondin-1 in human disease","volume":"122","author":"Esemuede","year":"2004","journal-title":"J. Surg. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0006-291X(90)92171-U","article-title":"Specific inhibition of endothelial cell proliferation by thrombospondin","volume":"170","author":"Bagavandoss","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1073\/pnas.88.11.5026","article-title":"Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro","volume":"88","author":"Bornstein","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3109\/07853890.2011.614635","article-title":"Thrombospondin-4, tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14: Novel extracellular matrix modulating factors in cardiac remodelling","volume":"44","author":"Mustonen","year":"2012","journal-title":"Ann. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ijcard.2013.04.139","article-title":"The role of thrombospondin-1 in cardiovascular health and pathology","volume":"168","author":"Krishna","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_7","unstructured":"Kaiser, R., Frantz, C., Bals, R., and Wilkens, H. (2010). The role of circulating thrombospondin-1 in patients with precapillary pulmonary hypertension. Respir. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/21548331.1985.11703207","article-title":"Methemoglobinemia in the differential diagnosis of cyanosis","volume":"20","year":"1985","journal-title":"Hosp. Pract."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0891-6632(91)90040-V","article-title":"The molecular biologic study of the expression of thrombospondin in vascular smooth muscle cells and mesangial cells","volume":"5","author":"Kobayashi","year":"1991","journal-title":"J. Diabet. Complicat."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1083\/jcb.93.2.343","article-title":"Synthesis and secretion of thrombospondin by cultured human endothelial cells","volume":"93","author":"Mosher","year":"1982","journal-title":"J. Cell Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0945-053X(00)00107-4","article-title":"The cell biology of thrombospondin-1","volume":"19","author":"Chen","year":"2000","journal-title":"Matrix. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/71517","article-title":"Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1","volume":"6","author":"Volpert","year":"2000","journal-title":"Nat. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mvr.2008.08.008","article-title":"The counteradhesive proteins, thrombospondin 1 and SPARC\/osteonectin, open the tyrosine phosphorylation-responsive paracellular pathway in pulmonary vascular endothelia","volume":"77","author":"Liu","year":"2009","journal-title":"Microvasc. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.1074\/jbc.M809198200","article-title":"Epidermal growth factor-like repeats of thrombospondins activate phospholipase Cgamma and increase epithelial cell migration through indirect epidermal growth factor receptor activation","volume":"284","author":"Liu","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.biocel.2004.01.005","article-title":"Coronary artery disease and the thrombospondin single nucleotide polymorphisms","volume":"36","author":"Stenina","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1161\/CIRCULATIONAHA.104.510354","article-title":"Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts","volume":"111","author":"Frangogiannis","year":"2005","journal-title":"Circulation"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/187152507779315813","article-title":"The role of the thrombospondins in healing myocardial infarcts","volume":"5","author":"Chatila","year":"2007","journal-title":"Cardiovasc. Hematol. Agents Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"12249","DOI":"10.3390\/ijms140612249","article-title":"Thrombospondin-1 in urological cancer: Pathological role, clinical significance, and therapeutic prospects","volume":"14","author":"Miyata","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3390\/ph3041241","article-title":"Thrombospondin-1 as a paradigm for the development of antiangiogenic agents endowed with multiple mechanisms of action","volume":"3","author":"Rusnati","year":"2010","journal-title":"Pharmaceuticals"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00018-007-7487-y","article-title":"The evolving role of thrombospondin-1 in hemostasis and vascular biology","volume":"65","author":"Bonnefoy","year":"2008","journal-title":"Cell Mol. Life Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"822","DOI":"10.2174\/138945008785909329","article-title":"Thrombospondin-1 in von Willebrand factor function","volume":"9","author":"Bonnefoy","year":"2008","journal-title":"Curr. Drug Targets"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s00018-007-7484-1","article-title":"Structures of thrombospondins","volume":"65","author":"Carlson","year":"2008","journal-title":"Cell Mol. Life Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"9396","DOI":"10.1074\/jbc.275.13.9396","article-title":"Interaction of thrombospondin-1 and heparansulfate from endothelial cells. Structural requirements of heparansulfate","volume":"275","author":"Feitsma","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1083\/jcb.138.3.707","article-title":"CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells","volume":"138","author":"Dawson","year":"1997","journal-title":"J. Cell. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1083\/jcb.135.2.533","article-title":"Thrombospondin modulates \u03b1V\u03b23 function through integrin-associated protein","volume":"135","author":"Gao","year":"1996","journal-title":"J. Cell Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1073\/pnas.68.1.240","article-title":"A thrombin-sensitive protein of human platelet membranes","volume":"68","author":"Baenziger","year":"1971","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4137\/BMI.S630","article-title":"The role of thrombospondin 1 on intestinal inflammation and carcinogenesis","volume":"3","author":"Gutierrez","year":"2008","journal-title":"Biomark. Insights"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.4049\/jimmunol.177.6.3534","article-title":"Thrombospondin\/CD47 interaction: A pathway to generate regulatory T cells from human CD4+ CD25\u2212 T cells in response to inflammation","volume":"177","author":"Grimbert","year":"2006","journal-title":"J. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.4049\/jimmunol.165.8.4624","article-title":"CD47 ligation selectively inhibits the development of human naive T cells into Th1 effectors","volume":"165","author":"Avice","year":"2000","journal-title":"J. Immunol."},{"key":"ref_30","first-page":"509","article-title":"Blockers of the RAA system: Perindopril and candesartan and their implication on endothelial dysfunction","volume":"XX","author":"Buda","year":"2014","journal-title":"Med. Evol."},{"key":"ref_31","first-page":"382","article-title":"The influence of perindopril on PTX3 plasma levels in hypertensive patients with endothelial dysfunction","volume":"64","author":"Buda","year":"2016","journal-title":"Farmacia"},{"key":"ref_32","first-page":"301","article-title":"The relationship between the bradykinins, RAAS and ACE inhibitors: An overview","volume":"XX","author":"Buda","year":"2014","journal-title":"Med. Evol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.2165\/00129784-200707050-00001","article-title":"ACE inhibition in hypertension","volume":"7","author":"Cockcroft","year":"2007","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/hr.2009.184","article-title":"Reinventing the ACE inhibitors: Some old and new implications of ACE inhibition","volume":"33","author":"Hanif","year":"2010","journal-title":"Hypertens. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1093\/eurheartj\/sum038","article-title":"Contribution of perindopril to cardiology: 20 years of success","volume":"9","author":"Fox","year":"2007","journal-title":"Eur. Heart J. Suppl."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1586\/14779072.3.1.15","article-title":"Angiotensin-converting enzyme inhibition in cardiovascular disease evidence with perindopril","volume":"3","author":"Ferrari","year":"2005","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1586\/erc.09.2","article-title":"Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease","volume":"7","author":"Brugts","year":"2009","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1440-1681.1992.tb02811.x","article-title":"Comparison of the pharmacokinetics and pharmacodynamics of perindopril, cilazapril and enalapril","volume":"19","author":"Louis","year":"1992","journal-title":"Clin. Exp. Pharmacol. Physiol. Suppl."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00005344-199209000-00024","article-title":"Single-dose and steady-state pharmacokinetics and pharmacodynamics of perindopril in hypertensive subjects","volume":"20","author":"Louis","year":"1992","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.matbio.2005.01.002","article-title":"Endogenous thrombospondin-1 is not necessary for proliferation but is permissive for vascular smooth muscle cell responses to platelet-derived growth factor","volume":"24","author":"Isenberg","year":"2005","journal-title":"Matrix. Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"26069","DOI":"10.1074\/jbc.M605040200","article-title":"CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1","volume":"281","author":"Isenberg","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.cardiores.2006.05.024","article-title":"Thrombospondin-1 antagonizes nitric oxide-stimulated vascular smooth muscle cell responses","volume":"71","author":"Isenberg","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5930","DOI":"10.4049\/jimmunol.178.9.5930","article-title":"Interactions between CD47 and thrombospondin reduce inflammation","volume":"178","author":"Lamy","year":"2007","journal-title":"J. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0002-9440(10)64243-5","article-title":"The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in double-TSP1\/TSP2-null mice","volume":"161","author":"Agah","year":"2002","journal-title":"Am. J. Pathol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.4049\/jimmunol.153.9.4219","article-title":"Thrombospondin promotes chemotaxis and haptotaxis of human peripheral blood monocytes","volume":"153","author":"Mansfield","year":"1994","journal-title":"J. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"7090","DOI":"10.1158\/0008-5472.CAN-08-0643","article-title":"Thrombospondin 1 promotes tumor macrophage recruitment and enhances tumor cell cytotoxicity of differentiated U937 cells","volume":"68","author":"Galli","year":"2008","journal-title":"Cancer Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.2337\/db07-0551","article-title":"Thrombospondin-1 is an endogenous activator of TGF-\u03b2 in experimental diabetic nephropathy in vivo","volume":"56","author":"Daniel","year":"2007","journal-title":"Diabetes"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1161\/HYPERTENSIONAHA.111.175323","article-title":"Endogenous thrombospondin 1 protects the pressure-overloaded myocardium by modulating fibroblast phenotype and matrix metabolism","volume":"58","author":"Xia","year":"2011","journal-title":"Hypertension"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"H2","DOI":"10.1152\/ajpheart.00471.2010","article-title":"Assessment of flow-mediated dilation in humans: A methodological and physiological guideline","volume":"300","author":"Thijssen","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/HYPERTENSIONAHA.110.150821","article-title":"Ultrasound assessment of flow-mediated dilation","volume":"55","author":"Harris","year":"2010","journal-title":"Hypertension"},{"key":"ref_52","first-page":"58","article-title":"Endothelial dysfunction\u2013methods of assessment and pharmacological approach in cardiovascular diseases","volume":"55","author":"Andor","year":"2005","journal-title":"TMJ"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","article-title":"Guidelines for the ultrasound assessment of endothelial dependent flow-mediated vasodilatation of the brachial artery: A report of the international brachial artery reactivity task force","volume":"39","author":"Correti","year":"2002","journal-title":"JACC"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000343145","article-title":"Mannheim carotid intima-media thickness and plaque consensus (2004\u20132006\u20132011)","volume":"34","author":"Touboul","year":"2012","journal-title":"Cerebrovasc. Dis."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/2\/348\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:27:36Z","timestamp":1760207256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/2\/348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,7]]},"references-count":54,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2]]}},"alternative-id":["ijms18020348"],"URL":"https:\/\/doi.org\/10.3390\/ijms18020348","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,7]]}}}